SPENDA LIMITED — Director's Dealing 2009

Sep 6, 2009

Medic Vision Limited (“Medic Vision” or the “Company”)

Directorate Change / Update re Extraordinary General Meeting

London, 4 September 2009

Medic Vision (ASX/AIM: MVH) announces the resignation of Ross Horley, effective 2 September 2009.

Mr Horley is leaving to pursue other business interests and the board of directors of the Company (the “Board”) would like to thank Ross for his considerable contribution during his tenure on the Board and to wish him all the best in his future endeavours. This announcement includes Mr Horley’s Final Director’s Interest Notice – Appendix 3Z (see below).

In accordance with ASX Listing Rules, an Australian public company must maintain a minimum number of three directors on the board. In the event that the number of directors falls below three, the ASX will suspend a company until such time as the requisite number of directors has been appointed.

The Company is already currently suspended from trading on the ASX, in accordance with ASX Listing Rule 12.2, pending the release of additional information and clarification concerning the Company’s financial condition. The Company is currently in discussion with the ASX and its auditors regarding Medic Vision's reinstatement to ASX listing.

Medic Vision’s reinstatement to ASX listing will not take effect until such time the ASX has been satisfied with regards to the Company’s financial condition and a minimum of three directors are appointed to the board.

The Board has identified a suitable candidate and a further announcement will be made, including the disclosures required by the AIM Rules, when the formal appointment is made which it is anticipated will be no later than 14 September 2009.

A further announcement in relation to the Company’s reinstatement to listing on ASX and the appointment of an additional director will be made in due course.

In addition, the Company is pleased to announce that Jitto Arulampalam has been appointed as Medic Vision’s Acting Company Secretary, replacing Mertons Corporate Services Pty Ltd with immediate effect.

The Company is pleased to confirm that it is in the process of finalising its Annual Financial Report for the year ended 30 June 2009 and expects to release its preliminary results towards the end of September 2009 / early October 2009 with the Annual Financial Report to be sent to shareholders shortly thereafter.

Further to the Company’s announcement, on 3 August 2009, regarding the intention to convene an extraordinary general meeting (“EGM”) in September 2009, the Board has decided to postpone convening of such EGM, so as to combine it with the AGM, which it is anticipated will be held during October 2009.

A further announcement in relation to the release of the preliminary results, posting of the Annual Financial Report and timing of the AGM / EGM will be made in due course.

For further information contact:

Vince Leone Chief Executive Officer & President Medic Vision

Email: vince.leone@medicvision.com.au Mob: +61 421 054 140

Stuart Faulkner / David Altberg

Tel: +44 20 7409 3494

Strand Partners Limited

Ruari McGirr St Helen’s Capital Plc

Tel: +44 20 7628 5582

Background on Medic Vision Limited

Medic Vision is a technology based company specialising in the application of technology for surgical and medical skills training. Medic Vision provides consulting services in the development of skills training centres as well as developing and deploying computer-based surgical and medical high fidelity simulators.

See www.medicvision.com.au for more details

Appendix 3Z

Final Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity MEDIC VISION LIMITED

ABN 67 099 084 143

We (the entity) give ASX the following information under listing rule 3.19A.3 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of director	Ross Horley
Date of last notice	17 November 2008
Date that director ceased to be director	2 September 2009

Part 1 – Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

5,213,074 ordinary shares

3,000,000 options (2,500,000 exercisable at $0.177 with expiry date of 30 November 2012, and 500,000 exercisable at $0.079, expiring on 3 May 2010)

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of interest	Number & class of securities
Note: Provide details of the circumstances giving rise to
the relevant interest

Part 3 – Director’s interests in contracts

Detail of contract	NA
Nature of interest	NA
Name of registered holder(if issued securities)	NA

No. and class of securities to which NA interest relates